HD Hyundai and TerraPower Sign Natrium® Reactor Supply Framework Agreement
Signed Agreement to establish Natrium reactor supply chain for serial production based on a year-long joint study HD Hyundai selected as a preferred manufacturer to supply Natrium Reactor Enclosure System (RES) components leveraging its world-class...
TECO Earns Global ESG Recognition with S&P Global Sustainability Yearbook and Dow Jones Best-in-Class Indices Inclusion
TAIPEI, May 13, 2026 /PRNewswire/ -- The S&P Global Sustainability Yearbook Awards Ceremony was held in Taipei on May 13. TECO Electric & Machinery Co., Ltd. (TWSE: 1504) was named to the 2026 edition of The Sustainability Yearbook by global...
LEIFRAS Co., Ltd. Re-selected to Provide Swimming Lesson Support for 1,757 Sessions Across 43 Schools in Fukuoka City
Physical Education Class Support Initiative Aims to Further Reduce Teacher Workloads TOKYO, May 12, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and...
450 MHz LTE: Stronger, Smarter Grid for Brazil
BELO HORIZONTE, Brazil, May 7, 2026 /PRNewswire/ -- Every day, millions of Brazilians press a button. They turn on a computer. They start a production machine. And energy simply happens. But what lies behind that button has become infinitely more...
2026 ASCO Preview | Results from Phase III Study of Anbenitamab (KN026) Combined with HB1801 in Neoadjuvant Treatment for Breast Cancer Selected for LBA Oral Presentation
SUZHOU, China, April 22, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the significant results from the Phase III clinical study (KN026-004) of HER2 bispecific antibody Anbenitamab Injection (KN026), independently...
HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI
Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in CC; TCV of new deal wins at $9.3B NEW YORK and NOIDA, India, April 22, 2026 /PRNewswire/ -- HCLTech, a leading global technology company, today reported financial results for...
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
-Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study . The fixed dose combination had...
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR
DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. OSLO, Norway, March 31, 2026 /PRNewswire/ -- DNV, a designated Notified Body for the European...
Oral Small Molecule Amylin Receptor Agonist ASC39 Demonstrated Eloralintide-like Amylin Selectivity and Efficacy in Preclinical Models
- In a head-to-head cyclic adenosine monophosphate (cAMP) activation assay vs. eloralintide, oral small molecule amylin receptor agonist ASC39 demonstrated similar selectivity and potency to that of eloralintide. EC 50 for human amylin 1 receptor...
Tejas Networks selected for a 4G network expansion project in South Asia
BENGALURU, India, March 16, 2026 /PRNewswire/ -- Tejas Networks (BSE: 540595) (NSE: TEJASNET) today announced that the company has received a purchase order to supply its state-of-the-art 4G RAN (Radio Access Network) solutions for a mobile network...